Table 4.
Changes in Clinical Scales From Day 0 to Day 42 by Treatment Group.
| Scale | SGB Injection | Placebo Injection | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | Mean | SD | Median | IQR | N | Mean | SD | Median | IQR | |
| MADRS | 3 | −0.3 | 2.1 | −1 | −1.5 to 0.5 | 5 | −11.1 | 11.7 | −4 | −13 to −4 |
| QIDS-SR | 3 | 1 | 1 | 1 | 0.5 to 1.5 | 5 | −6.4 | 6.1 | −6 | −9 to −3 |
| GAD-7 | 3 | 0 | 3.6 | 1 | −1.5 to 2 | 5 | −5.5 | 4.7 | −4 | −7 to −3 |
| Q-LES-Q | 3 | −0.3 | 1.5 | 0 | −1 to 0.5 | 5 | 7.6 | 6 | 8 | 4 to 8 |
Abbreviations: SGB, stellate ganglion block; IQR, interquartile range; MADRS, Montgomery-Åsberg Depression Rating Scale; QIDS-SR, Quick Inventory of Depressive Symptomatology – Self Report; GAD-7, Generalized Anxiety Disorder 7-item; Q-LES-Q, Quality-of-Life Enjoyment and Satisfaction.